Aarti Drugs Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 543.47 | 493.06 | 560.64 |
| Operating Expense | 483.55 | 438.73 | 490.47 |
| Net Profit | 30.39 | 26.91 | 36.14 |
| Net Profit Margin | 5.59 | 5.46 | 6.45 |
| Earning Per Share | 3.33 | 2.93 | 3.93 |
| EBIDTA | 57.92 | 53.83 | 71.67 |
| Effective Tax Rate | 14.19 | 14.26 | 21.52 |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 543.47 |
| Operating Expense | 483.55 |
| Net Profit | 30.39 |
| Net Profit Margin | 5.59 |
| Earning Per Share | 3.33 |
| EBIDTA | 57.92 |
| Effective Tax Rate | 14.19 |
Invest in Aarti Drugs Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 2,266.91 | 2,497.97 | 2,251.17 |
| Operating Expenses Annual | 2,000.78 | 2,215.57 | 1,932.99 |
| Operating Profit Annual | 270.31 | 284.64 | 322.96 |
| Interest Annual | 30.16 | 32.53 | 20.07 |
| Depreciation | 45.50 | 44.64 | 44.28 |
| Net Profit Annual | 141.88 | 152.81 | 195.00 |
| Tax Annual | 50.60 | 52 | 60.50 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 2,266.91 |
| Operating Expenses Annual | 2,000.78 |
| Operating Profit Annual | 270.31 |
| Interest Annual | 30.16 |
| Depreciation | 45.50 |
| Net Profit Annual | 141.88 |
| Tax Annual | 50.60 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 1.52 | 1.49 | 2.84 |
| Cash Flow from Operations | 337.10 | 161.70 | 39.90 |
| Cash Flow from Investing | -187.09 | -131.14 | -125.36 |
| Cash Flow from Financing | -148.81 | -30.54 | 84.11 |
| Cash Flow at the End | 2.72 | 1.52 | 1.49 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 1.52 |
| Cash Flow from Operations | 337.10 |
| Cash Flow from Investing | -187.09 |
| Cash Flow from Financing | -148.81 |
| Cash Flow at the End | 2.72 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 12.06 | 11.54 | 14.48 |
| PBIT Margin (%) | 9.96 | 9.65 | 12.37 |
| PBT Margin (%) | 9.66 | 9.38 | 11.83 |
| Net PROFIT Margin (%) | 6.26 | 6.12 | 8.66 |
| Return On Networth / Equity (%) | 12.39 | 14.65 | 21.29 |
| Return On Networth /Employed (%) | 13.65 | 15.24 | 20.38 |
| Return On Assets (%) | 8.57 | 9.67 | 14.29 |
| Total Debt / Equity (X) | 0.44 | 0.51 | 0.47 |
| Asset Turnover Ratio (%) | 1.37 | 1.58 | 1.65 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 12.06 |
| PBIT Margin (%) | 9.96 |
| PBT Margin (%) | 9.66 |
| Net PROFIT Margin (%) | 6.26 |
| Return On Networth / Equity (%) | 12.39 |
| Return On Networth /Employed (%) | 13.65 |
| Return On Assets (%) | 8.57 |
| Total Debt / Equity (X) | 0.44 |
| Asset Turnover Ratio (%) | 1.37 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 722.29 | 634.48 | 649.41 |
| Total Current Assets Annual | 1,181.02 | 1,349.53 | 1,273.19 |
| Non Current Assets Annual | 990.60 | 845.96 | 761.33 |
| Total Shareholders Funds Annual | 1,175.21 | 1,114.30 | 972.17 |
| Total Assets Annual | 2,171.62 | 2,195.50 | 2,034.52 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 722.29 |
| Total Current Assets Annual | 1,181.02 |
| Non Current Assets Annual | 990.60 |
| Total Shareholders Funds Annual | 1,175.21 |
| Total Assets Annual | 2,171.62 |
EPS (INR)
Expected
3.84
Reported
3.83
Surprise
-0.26%
Jun 2024
EPS beaten by -0.26%
Mar 2024
EPS beaten by 0.00%
Dec 2023
EPS beaten by 0.00%
